And for the time being, the FDA is not seeing anything alarming.
GLP-1 drugs have been used for decades to help people manage their bang out 2 diabetes.
The latest drug, Eli Lillys Zepbound, was approved by the FDA for obesity this past fall.
Injection pens of Novo Nordisk’s Ozempic, approved to treat type 2 diabetes.Image: Natalia Varlei (Shutterstock)
And its still possible that the agency could eventually find a genuine causative link between the two.
For now, the FDA is recommending that no one stop taking GLP-1s without first talking with their doctor.
News from the future, delivered to your present.